LISATA THERAPEUTICS, INC. Repayments of Bank Debt
LISATA THERAPEUTICS, INC. (LSTA) reported Repayments of Bank Debt of $7.83 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2012-03-20
- LISATA THERAPEUTICS, INC. repayments of bank debt for the quarter ending 2011-12-31 was $6.27M.
- LISATA THERAPEUTICS, INC. repayments of bank debt for the quarter ending 2010-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. repayments of bank debt for the quarter ending 2010-09-30 was -$5.85K.
- LISATA THERAPEUTICS, INC. repayments of bank debt for fiscal 2011 was $7.83M, a 255.29% increase from fiscal 2010.
- LISATA THERAPEUTICS, INC. repayments of bank debt for fiscal 2010 was $2.20M.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month | Repayments of Bank Debt 12 month |
|---|---|---|---|---|
| 2011-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | $7.83M 10-K · filed 2012-03-20 | ||
| 2011-09-30 | $1.56M 10-Q · filed 2011-11-10 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | -$5.85K derived: sum of 2 quarters · filed 2012-03-20 | $2.20M 10-K · filed 2012-03-20 | |
| 2010-09-30 | -$5.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $2.20M 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $2.21M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |